294 related articles for article (PubMed ID: 19875982)
1. Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.
Roodveldt C; Bertoncini CW; Andersson A; van der Goot AT; Hsu ST; Fernández-Montesinos R; de Jong J; van Ham TJ; Nollen EA; Pozo D; Christodoulou J; Dobson CM
EMBO J; 2009 Dec; 28(23):3758-70. PubMed ID: 19875982
[TBL] [Abstract][Full Text] [Related]
2. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
Chaari A; Hoarau-Véchot J; Ladjimi M
Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
[TBL] [Abstract][Full Text] [Related]
3. Human Hsp70 Disaggregase Reverses Parkinson's-Linked α-Synuclein Amyloid Fibrils.
Gao X; Carroni M; Nussbaum-Krammer C; Mogk A; Nillegoda NB; Szlachcic A; Guilbride DL; Saibil HR; Mayer MP; Bukau B
Mol Cell; 2015 Sep; 59(5):781-93. PubMed ID: 26300264
[TBL] [Abstract][Full Text] [Related]
4. Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.
Truttmann MC; Pincus D; Ploegh HL
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5008-E5017. PubMed ID: 29760078
[TBL] [Abstract][Full Text] [Related]
5. The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species.
Tittelmeier J; Sandhof CA; Ries HM; Druffel-Augustin S; Mogk A; Bukau B; Nussbaum-Krammer C
EMBO J; 2020 Jul; 39(13):e103954. PubMed ID: 32449565
[TBL] [Abstract][Full Text] [Related]
6. Hsp70 molecular chaperones and Parkinson's disease.
Witt SN
Biopolymers; 2010 Mar; 93(3):218-28. PubMed ID: 19768775
[TBL] [Abstract][Full Text] [Related]
7. Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease.
Sharma SK; Priya S
Cell Mol Life Sci; 2017 Feb; 74(4):617-629. PubMed ID: 27522545
[TBL] [Abstract][Full Text] [Related]
8. Stable alpha-synuclein oligomers strongly inhibit chaperone activity of the Hsp70 system by weak interactions with J-domain co-chaperones.
Hinault MP; Cuendet AF; Mattoo RU; Mensi M; Dietler G; Lashuel HA; Goloubinoff P
J Biol Chem; 2010 Dec; 285(49):38173-82. PubMed ID: 20847048
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70.
Batelli S; Albani D; Rametta R; Polito L; Prato F; Pesaresi M; Negro A; Forloni G
PLoS One; 2008 Apr; 3(4):e1884. PubMed ID: 18382667
[TBL] [Abstract][Full Text] [Related]
10. The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process.
Lenzi C; Ramazzina I; Russo I; Filippini A; Bettuzzi S; Rizzi F
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003328
[TBL] [Abstract][Full Text] [Related]
11. Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α-synuclein-elicited immune response.
Labrador-Garrido A; Cejudo-Guillén M; Daturpalli S; Leal MM; Klippstein R; De Genst EJ; Villadiego J; Toledo-Aral JJ; Dobson CM; Jackson SE; Pozo D; Roodveldt C
FASEB J; 2016 Feb; 30(2):564-77. PubMed ID: 26443817
[TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of amyloid disaggregation by human HSP70.
Wentink AS; Nillegoda NB; Feufel J; Ubartaitė G; Schneider CP; De Los Rios P; Hennig J; Barducci A; Bukau B
Nature; 2020 Nov; 587(7834):483-488. PubMed ID: 33177717
[TBL] [Abstract][Full Text] [Related]
13. What we know about ST13, a co-factor of heat shock protein, or a tumor suppressor?
Shi ZZ; Zhang JW; Zheng S
J Zhejiang Univ Sci B; 2007 Mar; 8(3):170-6. PubMed ID: 17323428
[TBL] [Abstract][Full Text] [Related]
14. FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.
Bao XQ; Wang XL; Zhang D
Mol Neurobiol; 2017 Jan; 54(1):349-361. PubMed ID: 26742515
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
16. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
[TBL] [Abstract][Full Text] [Related]
17. Chemical induction of Hsp70 reduces α-synuclein aggregation in neuroglioma cells.
Kilpatrick K; Novoa JA; Hancock T; Guerriero CJ; Wipf P; Brodsky JL; Segatori L
ACS Chem Biol; 2013 Jul; 8(7):1460-8. PubMed ID: 23594135
[TBL] [Abstract][Full Text] [Related]
18. Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism.
Tao J; Berthet A; Citron YR; Tsiolaki PL; Stanley R; Gestwicki JE; Agard DA; McConlogue L
J Biol Chem; 2021; 296():100613. PubMed ID: 33798554
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
20. DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease.
Ahmad A
Int J Biol Macromol; 2010 Mar; 46(2):275-9. PubMed ID: 20060408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
